Article info

Risk of morbidity and mortality in patients with type 2 diabetes treated with sodium-glucose cotransporter-2 inhibitor and/or dipeptidyl peptidase-4 inhibitor: a nationwide study

Authors

  1. Correspondence to Professor István Wittmann; istvan.wittmann{at}aok.pte.hu
View Full Text

Citation

Sütő G, Molnár GA, Rokszin G, et al
Risk of morbidity and mortality in patients with type 2 diabetes treated with sodium-glucose cotransporter-2 inhibitor and/or dipeptidyl peptidase-4 inhibitor: a nationwide study

Publication history

  • Received July 9, 2020
  • Revised December 12, 2020
  • Accepted December 30, 2020
  • First published January 20, 2021.
Online issue publication 
January 20, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.